Acceleron Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

30-01-2014 Business Wire HealthComments (0)

Acceleron Pharma

Acceleron Pharma (NASDAQ: XLRN) announces closing of its underwritten public offering of 2,760,000 shares of common stock, at $50/share. Net proceeds were approximately $129 million.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top